News

The Greek Diaspora Fellowship Program is a scholar exchange program for Greek universities to host Greek scholars from the diaspora in the areas of collaborative research, curriculum co-development and/or graduate/undergraduate student mentoring and teaching.

KGS researchers received $64,462 in funding from the U.S. Geological Survey's National Earthquake Hazards Reduction Program for their project, "Improving Estimates of Ground-Motion Site Response in the New Madrid and Wabash Valley Seismic Zones."

“The significance of addressing health and other inequities has never been greater,” said Nancy Schoenberg, CHET director. “While we received numerous rigorous proposals, these projects stood out for their capacity to employ stellar research approaches to make impactful change."

Emilia Galperin, a Kentucky College of Medicine researcher, has been awarded $1.9 million to continue research examining molecular pathogenesis of Noonan-like syndrome.

For more than a decade, Mohr-Schroeder has worked to remove barriers in order to facilitate authentic, hands-on educational opportunities for students in science, technology, engineering and mathematics, collectively known as STEM.

The program is for those who don’t receive a match to receive mentorship and experience to improve their resumé. UK’s program is one year, which gives fellows the time to reapply for residency programs by the next Match Day.

Recently, Asian needle ants invaded a home in south central Kentucky and stung the homeowner. This is one of the state’s first reports of the ants coming indoors. The insect has been in Kentucky since at least 2013 and in the U.S. since the 1930s.

In the wake of protests across the United States, corporate America is shifting away from “business-as-usual” and instead, sharing messages of solidarity — some even going as far as to launch new initiatives surrounding diversity and inclusion.

The new potential treatment has been added to the University of Kentucky’s innovative clinical trial for experimental COVID-19 therapies, which was launched by leaders from UK’s Markey Cancer Center, College of Medicine and College of Pharmacy in May.

UK announced a research collaboration with Atomwise, an industry leader in using artificial intelligence (AI) for small molecule discovery, to explore potential COVID-19 therapies.